Clinical Trial: Partnership for Research on Ebola VACcinations

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Partnership for Research on Ebola VACcinations (PREVAC)

Brief Summary: The purpose of this study is to evaluate the safety and immunogenicity of three vaccine strategies that may prevent Ebola virus disease (EVD) events in children and adults. Participants will receive either the Ad26.ZEBOV (rHAd26) vaccine with a MVA-BN-Filo (MVA) boost, or the rVSVΔG-ZEBOV-GP (rVSV) vaccine with or without boosting, or placebo.